Skip to main content
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
. 1982 Jan 1;126(1):31–33.

Juvenile dermatomyositis: medical, social and economic status in adulthood.

A Chalmers, R Sayson, K Walters
PMCID: PMC1862806  PMID: 7059870

Abstract

Eighteen adults were studied an average of 18.5 years after the diagnosis of juvenile dermatomyositis had been made. Persistent weakness was found in six patients and recurrent rash in the classic distribution in seven. Other clinical features present were Raynaud's phenomenon, arthritis and subcutaneous nodules. Minor increases in the serum creatine phosphokinase level were noted in seven patients and did not correlate with the presence of weakness or rash. Educational achievement and employment status were better in this group than in a group of adults with juvenile rheumatoid arthritis or the general adult population of British Columbia. Significant residual disability related to calcinosis and flexion contractures was present in only three of the patients.

Full text

PDF
31

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BITNUM S., DAESCHNER C. W., Jr, TRAVIS L. B., DODGE W. F., HOPPS H. C. DERMATOMYOSITIS. J Pediatr. 1964 Jan;64:101–131. doi: 10.1016/s0022-3476(64)80325-5. [DOI] [PubMed] [Google Scholar]
  2. COOK C. D., ROSEN F. S., BANKER B. Q. DERMATOMYOSITIS AND FOCAL SCLERODERMA. Pediatr Clin North Am. 1963 Nov;10:979–1016. doi: 10.1016/s0031-3955(16)31477-8. [DOI] [PubMed] [Google Scholar]
  3. Hill R. H., Herstein A., Walters K. Juvenile rheumatoid arthritis: follow-up into adulthood - medical, sexual and social status. Can Med Assoc J. 1976 May 8;114(9):790–796. [PMC free article] [PubMed] [Google Scholar]
  4. Hill R. H., Wood W. S. Juvenile dermatomyositis. Can Med Assoc J. 1970 Nov 21;103(11):1152–1156. [PMC free article] [PubMed] [Google Scholar]
  5. Medsger T. A., Jr, Robinson H., Masi A. T. Factors affecting survivorship in polymyositis. A life-table study of 124 patients. Arthritis Rheum. 1971 Mar-Apr;14(2):249–258. doi: 10.1002/art.1780140210. [DOI] [PubMed] [Google Scholar]
  6. Miller J. J., 3rd Late progression in dermatomyositis in childhood. J Pediatr. 1973 Oct;83(4):543–548. doi: 10.1016/s0022-3476(73)80212-4. [DOI] [PubMed] [Google Scholar]
  7. Pachman L. M., Cooke N. Juvenile dermatomyositis: a clinical and immunologic study. J Pediatr. 1980 Feb;96(2):226–234. doi: 10.1016/s0022-3476(80)80807-9. [DOI] [PubMed] [Google Scholar]
  8. Rose A. L. Childhood polymyositis. A follow-up study with special reference to treatment with corticosteroids. Am J Dis Child. 1974 Apr;127(4):518–522. doi: 10.1001/archpedi.1974.02110230064009. [DOI] [PubMed] [Google Scholar]
  9. Sullivan D. B., Cassidy J. T., Petty R. E., Burt A. Prognosis in childhood dermatomyositis. J Pediatr. 1972 Apr;80(4):555–563. doi: 10.1016/s0022-3476(72)80050-7. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES